The global transcatheter aortic valve implantation market revenue was US$ 5,197 million in 2021. The global transcatheter aortic valve implantation market revenue is forecast to reach US$ 16,937 million by 2030, registering a compound annual growth rate (CAGR) of 14.0% during the forecast period from 2022 to 2030.

Transcatheter aortic valve replacement is also known as transcatheter aortic valve implantation (TAVI). It is a minimally invasive procedure performed on high-risk patients who suffer from aortic stenosis. The TAVI procedure involves the implantation of transcatheter aortic valves to restore the aortic valves' blood flow capability.

Factors Influencing Market Growth 

• The global transcatheter aortic valve implantation market growth is primarily due to an increase in aortic stenosis prevalence, increased demand for various TAVI procedures, and advances in technology in the field.
• A rise in geriatrics populations is driving the global TAVI market growth since they are more likely to suffer from aortic stenosis.
• Increasing awareness about early diagnosis and technological advancements in TAVI valves propel the global market's growth. 
• Regulatory barriers to transcatheter aortic valve approval and high costs associated with TAVI may negatively impact the global market's growth.
• Several growth opportunities for the global transcatheter aortic valve implantation (TAVI) market will increase during the forecast period, including the use of TAVI systems for new indications, the rise in healthcare spending in emerging economies, and the increasing interest of key players in this field.

Impact Analysis of COVID-19

The COVID-19 pandemic impacted access to transcatheter aortic valve implantation for people living with aortic stenosis. The pandemic has prompted hospitals to implement protocols that minimize the use of anesthesiologists, ventilators, operating rooms, and intensive care beds. COVID-19 participants who underwent TAVI dealt with time delays, emergency procedures, and adverse outcomes. 

Regional Insights

Europe held dominant in the transcatheter aortic valve implantation market and is forecast to remain dominant during the forecast period. It is due to the presence of key players, the developed healthcare sector, and advancements in valve technology. TAVI in Europe has experienced growth due to an increase in cases of severe aortic stenosis, an increase in high-risk patients, and improved awareness among patients and physicians about the benefits of transcatheter aortic valves. A favorable reimbursement policy in certain European nations also contributes to adopting TAVI procedures in this region. 

North America is forecast to register the highest CAGR in the global market during the forecast period. Due to increased health care investments by manufacturers and high R&D expenditures by companies. In addition, the prevalence of coronary artery disease, hypertension, or heart failure contributes to the growth of the transcatheter aortic valve implantation market in North America.

Leading Competitors 

The leading prominent companies profiled in the global transcatheter aortic valve implantation market are:

• Abbott Laboratories
• Boston Scientific Corporation
• Blue Sail Medical Co. Limited
• Bracco Group
• Edward Lifesciences
• JC Medical Incorporated
• JenaValve Technology Incorporated
• Medtronic Plc
• Meril Life Sciences
• Venus MedTech HangZhou Incorporated
• Other Prominent Players

Scope of the Report

The global transcatheter aortic valve implantation market segmentation focuses on Procedure, End-User, and Region.

Segmentation based on Procedure

• Transfemoral Procedure
• Subclavian Procedure
• Others

Segmentation based on End-User

• Hospitals
• Ambulatory Surgical Centers
• Others

Segmentation based on Region

• North America
• The U.S.
• Canada
• Mexico
• Europe
• Western Europe
• The UK
• Germany
• France
• Italy
• Spain
• Rest of Western Europe
• Eastern Europe
• Poland
• Russia
• Rest of Eastern Europe
• Asia Pacific
• China
• India
• Japan
• Australia & New Zealand
• ASEAN
• Rest of Asia Pacific
• Middle East & Africa (MEA)
• UAE
• Saudi Arabia
• South Africa
• Rest of MEA
• South America
• Brazil
• Argentina
• Rest of South America